RNU6-287P

Across TCGA pan-cancer cohorts, RNU6-287P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-287P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RNU6-287P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-287P is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

KIRP and KICH are the cancer types where RNU6-287P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-287P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	−0.368	.003	4	view →
KICH	All	All	−0.170	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU6-287P–KIRP

Open the KIRP breakdown →